ID   CAD23_MOUSE             Reviewed;        3354 AA.
AC   Q99PF4; E9QP63; Q99NH1; Q9D4N9;
DT   16-NOV-2001, integrated into UniProtKB/Swiss-Prot.
DT   27-JUL-2011, sequence version 2.
DT   22-JUL-2015, entry version 118.
DE   RecName: Full=Cadherin-23;
DE   AltName: Full=Otocadherin;
DE   Flags: Precursor;
GN   Name=Cdh23;
OS   Mus musculus (Mouse).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi;
OC   Mammalia; Eutheria; Euarchontoglires; Glires; Rodentia; Sciurognathi;
OC   Muroidea; Muridae; Murinae; Mus; Mus.
OX   NCBI_TaxID=10090;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA], TISSUE SPECIFICITY, AND FUNCTION.
RC   STRAIN=C57BL/6J;
RX   PubMed=11138008; DOI=10.1038/83660;
RA   Di Palma F., Holme R.H., Bryda E.C., Belyantseva I.A., Pellegrino R.,
RA   Kachar B., Steel K.P., Noben-Trauth K.;
RT   "Mutations in Cdh23, encoding a new type of cadherin, cause
RT   stereocilia disorganization in waltzer, the mouse model for Usher
RT   syndrome type 1D.";
RL   Nat. Genet. 27:103-107(2001).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 2).
RC   TISSUE=Brain;
RX   PubMed=11386759; DOI=10.1006/geno.2001.6554;
RA   Wilson S.M., Householder D.B., Coppola V., Tessarollo L., Fritzsch B.,
RA   Lee E.-C., Goss D., Carlson G.A., Copeland N.G., Jenkins N.A.;
RT   "Mutations in Cdh23 cause nonsyndromic hearing loss in waltzer mice.";
RL   Genomics 74:228-233(2001).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC   STRAIN=C57BL/6J; TISSUE=Testis;
RX   PubMed=16141072; DOI=10.1126/science.1112014;
RA   Carninci P., Kasukawa T., Katayama S., Gough J., Frith M.C., Maeda N.,
RA   Oyama R., Ravasi T., Lenhard B., Wells C., Kodzius R., Shimokawa K.,
RA   Bajic V.B., Brenner S.E., Batalov S., Forrest A.R., Zavolan M.,
RA   Davis M.J., Wilming L.G., Aidinis V., Allen J.E.,
RA   Ambesi-Impiombato A., Apweiler R., Aturaliya R.N., Bailey T.L.,
RA   Bansal M., Baxter L., Beisel K.W., Bersano T., Bono H., Chalk A.M.,
RA   Chiu K.P., Choudhary V., Christoffels A., Clutterbuck D.R.,
RA   Crowe M.L., Dalla E., Dalrymple B.P., de Bono B., Della Gatta G.,
RA   di Bernardo D., Down T., Engstrom P., Fagiolini M., Faulkner G.,
RA   Fletcher C.F., Fukushima T., Furuno M., Futaki S., Gariboldi M.,
RA   Georgii-Hemming P., Gingeras T.R., Gojobori T., Green R.E.,
RA   Gustincich S., Harbers M., Hayashi Y., Hensch T.K., Hirokawa N.,
RA   Hill D., Huminiecki L., Iacono M., Ikeo K., Iwama A., Ishikawa T.,
RA   Jakt M., Kanapin A., Katoh M., Kawasawa Y., Kelso J., Kitamura H.,
RA   Kitano H., Kollias G., Krishnan S.P., Kruger A., Kummerfeld S.K.,
RA   Kurochkin I.V., Lareau L.F., Lazarevic D., Lipovich L., Liu J.,
RA   Liuni S., McWilliam S., Madan Babu M., Madera M., Marchionni L.,
RA   Matsuda H., Matsuzawa S., Miki H., Mignone F., Miyake S., Morris K.,
RA   Mottagui-Tabar S., Mulder N., Nakano N., Nakauchi H., Ng P.,
RA   Nilsson R., Nishiguchi S., Nishikawa S., Nori F., Ohara O.,
RA   Okazaki Y., Orlando V., Pang K.C., Pavan W.J., Pavesi G., Pesole G.,
RA   Petrovsky N., Piazza S., Reed J., Reid J.F., Ring B.Z., Ringwald M.,
RA   Rost B., Ruan Y., Salzberg S.L., Sandelin A., Schneider C.,
RA   Schoenbach C., Sekiguchi K., Semple C.A., Seno S., Sessa L., Sheng Y.,
RA   Shibata Y., Shimada H., Shimada K., Silva D., Sinclair B.,
RA   Sperling S., Stupka E., Sugiura K., Sultana R., Takenaka Y., Taki K.,
RA   Tammoja K., Tan S.L., Tang S., Taylor M.S., Tegner J., Teichmann S.A.,
RA   Ueda H.R., van Nimwegen E., Verardo R., Wei C.L., Yagi K.,
RA   Yamanishi H., Zabarovsky E., Zhu S., Zimmer A., Hide W., Bult C.,
RA   Grimmond S.M., Teasdale R.D., Liu E.T., Brusic V., Quackenbush J.,
RA   Wahlestedt C., Mattick J.S., Hume D.A., Kai C., Sasaki D., Tomaru Y.,
RA   Fukuda S., Kanamori-Katayama M., Suzuki M., Aoki J., Arakawa T.,
RA   Iida J., Imamura K., Itoh M., Kato T., Kawaji H., Kawagashira N.,
RA   Kawashima T., Kojima M., Kondo S., Konno H., Nakano K., Ninomiya N.,
RA   Nishio T., Okada M., Plessy C., Shibata K., Shiraki T., Suzuki S.,
RA   Tagami M., Waki K., Watahiki A., Okamura-Oho Y., Suzuki H., Kawai J.,
RA   Hayashizaki Y.;
RT   "The transcriptional landscape of the mammalian genome.";
RL   Science 309:1559-1563(2005).
RN   [4]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RC   STRAIN=C57BL/6J;
RX   PubMed=19468303; DOI=10.1371/journal.pbio.1000112;
RA   Church D.M., Goodstadt L., Hillier L.W., Zody M.C., Goldstein S.,
RA   She X., Bult C.J., Agarwala R., Cherry J.L., DiCuccio M., Hlavina W.,
RA   Kapustin Y., Meric P., Maglott D., Birtle Z., Marques A.C., Graves T.,
RA   Zhou S., Teague B., Potamousis K., Churas C., Place M., Herschleb J.,
RA   Runnheim R., Forrest D., Amos-Landgraf J., Schwartz D.C., Cheng Z.,
RA   Lindblad-Toh K., Eichler E.E., Ponting C.P.;
RT   "Lineage-specific biology revealed by a finished genome assembly of
RT   the mouse.";
RL   PLoS Biol. 7:E1000112-E1000112(2009).
RN   [5]
RP   GENOMIC ORGANIZATION, ALTERNATIVE SPLICING, VARIANT WALTZER
RP   2718-ASN--PRO-2720 DEL, AND VARIANTS PRO-5; VAL-229; LYS-891;
RP   ILE-1137; ARG-1236; VAL-2025; VAL-2026; THR-2217; HIS-2222; ARG-2270
RP   AND ALA-2617.
RC   STRAIN=C57BL/6J, and CAST/Ei;
RX   PubMed=11750125; DOI=10.1016/S0378-1119(01)00761-2;
RA   Di Palma F., Pellegrino R., Noben-Trauth K.;
RT   "Genomic structure, alternative splice forms and normal and mutant
RT   alleles of cadherin 23 (Cdh23).";
RL   Gene 281:31-41(2001).
RN   [6]
RP   INTERACTION WITH PCDH15.
RX   PubMed=17805295; DOI=10.1038/nature06091;
RA   Kazmierczak P., Sakaguchi H., Tokita J., Wilson-Kubalek E.M.,
RA   Milligan R.A., Muller U., Kachar B.;
RT   "Cadherin 23 and protocadherin 15 interact to form tip-link filaments
RT   in sensory hair cells.";
RL   Nature 449:87-91(2007).
RN   [7]
RP   X-RAY CRYSTALLOGRAPHY (1.5 ANGSTROMS) OF 24-228 IN COMPLEX WITH
RP   CALCIUM.
RX   PubMed=20399731; DOI=10.1016/j.neuron.2010.03.028;
RA   Sotomayor M., Weihofen W.A., Gaudet R., Corey D.P.;
RT   "Structural determinants of cadherin-23 function in hearing and
RT   deafness.";
RL   Neuron 66:85-100(2010).
RN   [8]
RP   X-RAY CRYSTALLOGRAPHY (1.1 ANGSTROMS) OF 24-233 IN COMPLEX WITH
RP   CALCIUM, MUTAGENESIS OF ASN-26 AND ARG-27, AND INTERACTION WITH
RP   PCDH15.
RX   PubMed=20498078; DOI=10.1073/pnas.1006284107;
RA   Elledge H.M., Kazmierczak P., Clark P., Joseph J.S., Kolatkar A.,
RA   Kuhn P., Muller U.;
RT   "Structure of the N terminus of cadherin 23 reveals a new adhesion
RT   mechanism for a subset of cadherin superfamily members.";
RL   Proc. Natl. Acad. Sci. U.S.A. 107:10708-10712(2010).
RN   [9]
RP   X-RAY CRYSTALLOGRAPHY (1.65 ANGSTROMS) OF 24-228 IN COMPLEX WITH
RP   CALCIUM IONS AND PCDH15, SUBUNIT, AND MUTAGENESIS OF LEU-168.
RX   PubMed=23135401; DOI=10.1038/nature11590;
RA   Sotomayor M., Weihofen W.A., Gaudet R., Corey D.P.;
RT   "Structure of a force-conveying cadherin bond essential for inner-ear
RT   mechanotransduction.";
RL   Nature 492:128-132(2012).
CC   -!- FUNCTION: Cadherins are calcium-dependent cell adhesion proteins.
CC       They preferentially interact with themselves in a homophilic
CC       manner in connecting cells. CDH23 is required for establishing
CC       and/or maintaining the proper organization of the stereocilia
CC       bundle of hair cells in the cochlea and the vestibule during late
CC       embryonic/early postnatal development. It is part of the
CC       functional network formed by USH1C, USH1G, CDH23 and MYO7A that
CC       mediates mechanotransduction in cochlear hair cells. Required for
CC       normal hearing. {ECO:0000269|PubMed:11138008}.
CC   -!- SUBUNIT: Interacts with USH1C and USH1G (By similarity).
CC       antiparallel heterodimer with PCDH15. {ECO:0000250,
CC       ECO:0000269|PubMed:17805295, ECO:0000269|PubMed:20399731,
CC       ECO:0000269|PubMed:20498078, ECO:0000269|PubMed:23135401}.
CC   -!- INTERACTION:
CC       Q9ES64-3:Ush1c; NbExp=2; IntAct=EBI-7419021, EBI-7418919;
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000250}; Single-pass
CC       type I membrane protein {ECO:0000250}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=2;
CC       Name=1;
CC         IsoId=Q99PF4-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q99PF4-2; Sequence=VSP_000648;
CC   -!- TISSUE SPECIFICITY: In adult animals relatively high levels of
CC       expression are found in testis, skeletal muscle, heart, eye and
CC       thymus, and lower expression in kidney, lung and brain. Found in
CC       the sensory hair cells of the inner ear.
CC       {ECO:0000269|PubMed:11138008}.
CC   -!- DOMAIN: Three calcium ions are usually bound at the interface of
CC       each cadherin domain and rigidify the connections, imparting a
CC       strong curvature to the full-length ectodomain. {ECO:0000250}.
CC   -!- DOMAIN: Cadherin repeats 1 and 2 mediate calcium-dependent
CC       heterophilic interaction with PCDH15.
CC       {ECO:0000269|PubMed:23135401}.
CC   -!- DISEASE: Note=Defects in Cdh23 are the cause of waltzer (v)
CC       phenotype. Waltzer mice are characterized by deafness and
CC       vestibular dysfunction due to degeneration of the neuroepithelium
CC       within the inner ear.
CC   -!- SIMILARITY: Contains 27 cadherin domains. {ECO:0000255|PROSITE-
CC       ProRule:PRU00043}.
CC   -----------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see http://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution-NoDerivs License
CC   -----------------------------------------------------------------------
DR   EMBL; AF308939; AAG52817.1; -; mRNA.
DR   EMBL; AY026062; AAK07670.1; -; mRNA.
DR   EMBL; AK016365; -; NOT_ANNOTATED_CDS; mRNA.
DR   EMBL; AC079082; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079818; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC079819; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; AC153517; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   RefSeq; NP_075859.2; NM_023370.3.
DR   UniGene; Mm.440327; -.
DR   PDB; 2WBX; X-ray; 1.50 A; A=24-124.
DR   PDB; 2WCP; X-ray; 1.98 A; A=24-228.
DR   PDB; 2WD0; X-ray; 2.74 A; A/C=24-228.
DR   PDB; 2WHV; X-ray; 2.36 A; A=24-228.
DR   PDB; 3MVS; X-ray; 1.10 A; A=24-233.
DR   PDB; 4APX; X-ray; 1.65 A; A=24-228.
DR   PDB; 4AQ8; X-ray; 2.63 A; A/B=24-228.
DR   PDB; 4AQA; X-ray; 1.96 A; A=24-228.
DR   PDB; 4AQE; X-ray; 2.27 A; A=24-228.
DR   PDB; 4AXW; X-ray; 2.23 A; A=24-228.
DR   PDBsum; 2WBX; -.
DR   PDBsum; 2WCP; -.
DR   PDBsum; 2WD0; -.
DR   PDBsum; 2WHV; -.
DR   PDBsum; 3MVS; -.
DR   PDBsum; 4APX; -.
DR   PDBsum; 4AQ8; -.
DR   PDBsum; 4AQA; -.
DR   PDBsum; 4AQE; -.
DR   PDBsum; 4AXW; -.
DR   ProteinModelPortal; Q99PF4; -.
DR   SMR; Q99PF4; 24-233.
DR   BioGrid; 204475; 1.
DR   DIP; DIP-42152N; -.
DR   IntAct; Q99PF4; 1.
DR   MINT; MINT-1895823; -.
DR   STRING; 10090.ENSMUSP00000101104; -.
DR   PhosphoSite; Q99PF4; -.
DR   PaxDb; Q99PF4; -.
DR   PRIDE; Q99PF4; -.
DR   Ensembl; ENSMUST00000105461; ENSMUSP00000101101; ENSMUSG00000012819. [Q99PF4-1]
DR   Ensembl; ENSMUST00000105463; ENSMUSP00000101103; ENSMUSG00000012819. [Q99PF4-2]
DR   GeneID; 22295; -.
DR   UCSC; uc033fpl.1; mouse. [Q99PF4-1]
DR   CTD; 64072; -.
DR   MGI; MGI:1890219; Cdh23.
DR   eggNOG; NOG12793; -.
DR   GeneTree; ENSGT00760000118805; -.
DR   HOGENOM; HOG000139588; -.
DR   HOVERGEN; HBG050768; -.
DR   InParanoid; Q99PF4; -.
DR   OMA; EDMTFRM; -.
DR   TreeFam; TF316403; -.
DR   EvolutionaryTrace; Q99PF4; -.
DR   NextBio; 302447; -.
DR   PRO; PR:Q99PF4; -.
DR   Proteomes; UP000000589; Chromosome 10.
DR   Bgee; Q99PF4; -.
DR   ExpressionAtlas; Q99PF4; baseline and differential.
DR   Genevisible; Q99PF4; MM.
DR   GO; GO:0005813; C:centrosome; IDA:MGI.
DR   GO; GO:0005829; C:cytosol; ISO:MGI.
DR   GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR   GO; GO:0060091; C:kinocilium; IDA:MGI.
DR   GO; GO:0001917; C:photoreceptor inner segment; IDA:MGI.
DR   GO; GO:0005886; C:plasma membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0032420; C:stereocilium; IDA:HGNC.
DR   GO; GO:0032426; C:stereocilium bundle tip; IDA:MGI.
DR   GO; GO:0045202; C:synapse; IDA:MGI.
DR   GO; GO:0005509; F:calcium ion binding; IEA:InterPro.
DR   GO; GO:0042491; P:auditory receptor cell differentiation; IMP:MGI.
DR   GO; GO:0060088; P:auditory receptor cell stereocilium organization; IMP:MGI.
DR   GO; GO:0006816; P:calcium ion transport; ISO:MGI.
DR   GO; GO:0016339; P:calcium-dependent cell-cell adhesion via plasma membrane cell adhesion molecules; ISS:MGI.
DR   GO; GO:0007155; P:cell adhesion; TAS:MGI.
DR   GO; GO:0051480; P:cytosolic calcium ion homeostasis; ISO:MGI.
DR   GO; GO:0050957; P:equilibrioception; ISO:MGI.
DR   GO; GO:0007156; P:homophilic cell adhesion via plasma membrane adhesion molecules; IEA:InterPro.
DR   GO; GO:0048839; P:inner ear development; IMP:MGI.
DR   GO; GO:0042472; P:inner ear morphogenesis; IMP:MGI.
DR   GO; GO:0060122; P:inner ear receptor stereocilium organization; IMP:MGI.
DR   GO; GO:0007626; P:locomotory behavior; IMP:MGI.
DR   GO; GO:0045494; P:photoreceptor cell maintenance; ISO:MGI.
DR   GO; GO:0048563; P:post-embryonic organ morphogenesis; IMP:MGI.
DR   GO; GO:0050953; P:sensory perception of light stimulus; IMP:MGI.
DR   GO; GO:0007605; P:sensory perception of sound; IMP:MGI.
DR   Gene3D; 2.60.40.60; -; 27.
DR   InterPro; IPR002126; Cadherin.
DR   InterPro; IPR015919; Cadherin-like.
DR   InterPro; IPR020894; Cadherin_CS.
DR   Pfam; PF00028; Cadherin; 24.
DR   PRINTS; PR00205; CADHERIN.
DR   SMART; SM00112; CA; 26.
DR   SUPFAM; SSF49313; SSF49313; 27.
DR   PROSITE; PS00232; CADHERIN_1; 17.
DR   PROSITE; PS50268; CADHERIN_2; 27.
PE   1: Evidence at protein level;
KW   3D-structure; Alternative splicing; Calcium; Cell adhesion;
KW   Cell membrane; Complete proteome; Deafness; Disease mutation;
KW   Glycoprotein; Hearing; Membrane; Metal-binding;
KW   Non-syndromic deafness; Polymorphism; Reference proteome; Repeat;
KW   Signal; Transmembrane; Transmembrane helix.
FT   SIGNAL        1     23       {ECO:0000255}.
FT   CHAIN        24   3354       Cadherin-23.
FT                                /FTId=PRO_0000003825.
FT   TOPO_DOM     24   3064       Extracellular. {ECO:0000255}.
FT   TRANSMEM   3065   3085       Helical. {ECO:0000255}.
FT   TOPO_DOM   3086   3354       Cytoplasmic. {ECO:0000255}.
FT   DOMAIN       34    132       Cadherin 1. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      133    236       Cadherin 2. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      237    348       Cadherin 3. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      349    460       Cadherin 4. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      461    561       Cadherin 5. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      562    671       Cadherin 6. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      672    784       Cadherin 7. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      779    890       Cadherin 8. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      891    995       Cadherin 9. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN      996   1102       Cadherin 10. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1103   1208       Cadherin 11. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1210   1313       Cadherin 12. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1314   1418       Cadherin 13. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1420   1527       Cadherin 14. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1529   1634       Cadherin 15. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1635   1744       Cadherin 16. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1745   1851       Cadherin 17. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1852   1959       Cadherin 18. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     1960   2069       Cadherin 19. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2070   2174       Cadherin 20. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2175   2293       Cadherin 21. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2297   2402       Cadherin 22. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2403   2509       Cadherin 23. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2510   2611       Cadherin 24. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2614   2722       Cadherin 25. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2729   2846       Cadherin 26. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   DOMAIN     2847   2975       Cadherin 27. {ECO:0000255|PROSITE-
FT                                ProRule:PRU00043}.
FT   CARBOHYD    155    155       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    206    206       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    349    349       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    393    393       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    434    434       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    466    466       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    472    472       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    602    602       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    694    694       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    765    765       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    810    810       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    827    827       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD    941    941       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1001   1001       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1018   1018       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1171   1171       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1282   1282       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1315   1315       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1473   1473       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1534   1534       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1651   1651       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1667   1667       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1818   1818       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1857   1857       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1889   1889       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   1902   1902       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2014   2014       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2050   2050       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2129   2129       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2168   2168       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2195   2195       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2263   2263       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2357   2357       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2369   2369       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2578   2578       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2616   2616       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2749   2749       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2808   2808       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2877   2877       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2896   2896       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2941   2941       N-linked (GlcNAc...). {ECO:0000255}.
FT   CARBOHYD   2981   2981       N-linked (GlcNAc...). {ECO:0000255}.
FT   VAR_SEQ    3212   3246       Missing (in isoform 2).
FT                                {ECO:0000303|PubMed:11386759}.
FT                                /FTId=VSP_000648.
FT   VARIANT       5      5       L -> P (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT     229    229       M -> V (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT     891    891       R -> K (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    1137   1137       V -> I (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    1236   1236       K -> R (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2025   2025       I -> V (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2026   2026       I -> V (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2217   2217       K -> T (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2222   2222       R -> H (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2270   2270       H -> R (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2617   2617       G -> A (in strain: CAST/Ei).
FT                                {ECO:0000269|PubMed:11750125}.
FT   VARIANT    2718   2720       Missing (in waltzer).
FT                                {ECO:0000269|PubMed:11750125}.
FT   MUTAGEN      26     26       N->I: Strongly reduced affinity for
FT                                PCDH15. {ECO:0000269|PubMed:20498078}.
FT   MUTAGEN      27     27       R->I: Strongly reduced affinity for
FT                                PCDH15. {ECO:0000269|PubMed:20498078}.
FT   MUTAGEN     168    168       L->G: Strongly reduced interaction with
FT                                PCDH15. {ECO:0000269|PubMed:23135401}.
FT   CONFLICT     94     94       D -> G (in Ref. 2; AAK07670).
FT                                {ECO:0000305}.
FT   CONFLICT    142    143       PE -> TQ (in Ref. 2; AAK07670).
FT                                {ECO:0000305}.
FT   CONFLICT    248    251       HSPP -> QLTVNAT (in Ref. 2; AAK07670).
FT                                {ECO:0000305}.
FT   CONFLICT    379    379       D -> N (in Ref. 1; AAG52817 and 2;
FT                                AAK07670). {ECO:0000305}.
FT   CONFLICT   3128   3128       S -> A (in Ref. 1; AAG52817 and 2;
FT                                AAK07670). {ECO:0000305}.
FT   CONFLICT   3262   3262       G -> S (in Ref. 1; AAG52817).
FT                                {ECO:0000305}.
FT   HELIX        34     36       {ECO:0000244|PDB:3MVS}.
FT   STRAND       40     43       {ECO:0000244|PDB:3MVS}.
FT   STRAND       51     54       {ECO:0000244|PDB:3MVS}.
FT   STRAND       66     71       {ECO:0000244|PDB:3MVS}.
FT   HELIX        72     77       {ECO:0000244|PDB:3MVS}.
FT   STRAND       78     80       {ECO:0000244|PDB:3MVS}.
FT   TURN         82     84       {ECO:0000244|PDB:3MVS}.
FT   STRAND       86     91       {ECO:0000244|PDB:3MVS}.
FT   TURN         95     97       {ECO:0000244|PDB:3MVS}.
FT   STRAND      100    108       {ECO:0000244|PDB:3MVS}.
FT   STRAND      113    123       {ECO:0000244|PDB:3MVS}.
FT   STRAND      131    134       {ECO:0000244|PDB:4APX}.
FT   STRAND      136    142       {ECO:0000244|PDB:3MVS}.
FT   STRAND      150    153       {ECO:0000244|PDB:3MVS}.
FT   HELIX       162    165       {ECO:0000244|PDB:3MVS}.
FT   STRAND      167    173       {ECO:0000244|PDB:3MVS}.
FT   STRAND      176    180       {ECO:0000244|PDB:3MVS}.
FT   TURN        182    184       {ECO:0000244|PDB:3MVS}.
FT   STRAND      186    189       {ECO:0000244|PDB:3MVS}.
FT   TURN        195    197       {ECO:0000244|PDB:3MVS}.
FT   STRAND      199    209       {ECO:0000244|PDB:3MVS}.
FT   STRAND      212    214       {ECO:0000244|PDB:3MVS}.
FT   STRAND      217    227       {ECO:0000244|PDB:3MVS}.
SQ   SEQUENCE   3354 AA;  369623 MW;  6ADFABF6A5001DC0 CRC64;
     MRYSLVTCYA VLWLLMLVPG SWGQVNRLPF FTNHFFDTYL LISEDTPVGS SVTQLLARDM
     DNDPLVFGVS GEEASRFFAV EPDTGVVWLR QPLDRETKSE FTVEFSVSDH QGVITRKVNI
     QVGDVNDNAP TFHNQPYSVR IPENTPVGTP IFIVNATDPD LGAGGSVLYS FQPPSPFFAI
     DSARGIVTVI QELDYEVTQA YQLTVNATDQ DKTRPLSTLA NLAIIITDMQ DMDPIFINLP
     YSTNIYEHSP PGTTVRVITA VDQDKGRPRG IGYTIVSGNT NSIFALDYIS GALTLNGLLD
     RENPLYSHGF ILTVKGTELN DDRTPSDATV TTTFNILVID INDNAPEFNS SEYSVAITEL
     AQVGFALPLF IQVVDKDEDL GLNSMFEVYL VGNNSHHFII SPTSVQGKAD IRIRVAIPLD
     YETVDRYDFD LFANESVPDH VGYAKVKITL INENDNRPIF SQPLYNVSLY ENITVGTSVL
     TVLATDNDVG TFGEVNYFFS DDPDRFSLDK DTGLIMLIAR LDYELIQRFT LTVIARDGGG
     EETTGRVRIN VLDVNDNVPT FQKDAYVGAL RENEPSVTQL VRLRATDEDS PPNNLITYSI
     VNASAFGSYF DISIYEGYGV ISVSRPLDYE QIPNGLIYLT VMAKDAGNPP LYSTVPVTIE
     VFDENDNPPT FSKPAYFVSV LENIMAGATV LFLNATDLDR SREYGQESII YSLEGSSQFR
     INARSGEITT TSLLDRETKS EYILIVRAVD GGVGHNQKTG IATVNVTLLD INDNHPTWKD
     APYYINLVEM TPPDSDVTTV VAVDPDLGEN GTLVYSIHPP NKFYSLNSTT GKIRTTHVML
     DRENPDPVEA ELMRKIIVSV TDCGRPPLKA TSSATVFVNL LDLNDNDPTF RNLPFVAEIL
     EGTPAGVSVY QVVAIDLDEG LNGLVSYRMQ VGMPRMDFVI NSTSGVVTTT AELDRERIAE
     YQLRVVASDA GTPTKSSTST LTVRVLDVND ETPTFFPAVY NVSVSEDVPR EFRVVWLNCT
     DNDVGLNAEL SYFITAGNVD GKFSVGYRDA VVRTVVGLDR ETTAAYTLVL EAIDNGPVGK
     RRTGTATVFV TVLDVNDNRP IFLQSSYEAS VPEDIPEGHS IVQLKATDAD EGEFGRVWYR
     ILHGNHGNNF RIHVGSGLLM RGPRPLDRER NSSHVLMVEA YNHDLGPMRS SVRVIVYVED
     VNDEAPVFTQ QQYNRLGLRE TAGIGTSVIV VRATDKDTGD GGLVNYRILS GAEGKFEIDE
     STGLIVTVDY LDYETKTSYL MNVSATDGAP PFNQGFCSVY VTLLNELDEA VQFSNASYEA
     VIMENLALGT EIVRVQAYSI DNLNQITYRF DAYTSAQAKA LFKIDAITGV ITVKGLVDRE
     KGDFYTLTVV ADDGGPKVDS TVKVYITVLD ENDNSPRFDF TSDSAISVPE DCPVGQRVAT
     VKARDPDAGS NGQVVFSLAS GNIAGAFEII TSNDSIGEVF VAKPLDREEL DHYILKVVAS
     DRGTPPRKKD HILQVTILDV NDNPPVIESP FGYNVSVNEN VGGGTSVVQV RATDRDIGIN
     SVLSYYITEG NEDMTFRMDR ISGEIATRPA PPDRERQNFY HLVVTVEDEG TPTLSATTHV
     YVTIVDENDN APVFQQPHYE VVLDEGPDTI NTSLITVQAL DLDEGPNGTV TYAIVAGNII
     NTFRINKHTG VITAAKELDY EISHGRYTLI VTATDQCPIL SHRLTSTTTV LVNVNDINDN
     VPTFPRDYEG PFDVTEGQPG PRVWTFLAHD RDSGPNGQVE YSVVDGDPLG EFVISPVEGV
     LRVRKDVELD RETIAFYNLT ICARDRGVPP LSSTMLVGIR VLDINDNDPV LLNLPMNVTI
     SENSPVSSFV AHVLASDADS GCNALLTFNI TAGNRERAFF INATTGIVTV NRPLDRERIP
     EYRLTVSVKD NPENPRIARK DFDLLLVSLA DENDNHPLFT EGTYQAEVME NSPAGTPLTV
     LNGPILALDA DEDVYAVVTY QLLGTHSDLF VIDNSTGVVT VRSGIIIDRE AFSPPFLELL
     LLAEDIGQLN GTAHLFITIL DDNDNWPTFS PPTYTVHLLE NCPPGFSVLQ VTATDEDSGL
     NGELVYRIEA GAQDRFLIHP VTGVIRVGNA TIDREEQESY RLTVVATDRG TVPLSGTAIV
     TILIDDINDS RPEFLNPIQT VSVLESAEPG TIIANVTAID LDLNPKLEYH IISIVAKDDT
     DRLVPDQEDA FAVNINTGSV MVKSPLNREL VATYEVTLSV IDNASDLPEH SVSVPNAKLT
     VNILDVNDNT PQFKPFGITY YTERVLEGAT PGTTLIAVAA VDPDKGLNGL ITYTLLDLTP
     PGYVQLEDSS AGKVIANRTV DYEEVHWLNF TVRASDNGSP PRAAEIPVYL EIVDINDNNP
     IFDQPSYQEA VFEDIAVGTV ILRVTATDAD SGNFALIEYS LVDGEGKFAI NPNTGDISVL
     SSLDREKKDH YILTALAKDN PGDVASNRRE NSVQVVIRVL DVNDCRPQFS KPQFSTSVYE
     NEPAGTSVIT MLATDQDEGS NSQLTYSLEG PGMEAFSVDM DSGLVTTQRP LQSYERFNLT
     VVATDGGEPP LWGTTMLLVE VIDVNDNRPV FVRPPNGTIL HIKEEIPLRS NVYEVYATDN
     DEGLNGAVRY SFLKTTGNRD WEYFTIDPIS GLIQTAQRLD REKQAVYSLI LVASDLGQPV
     PYETMQPLQV ALEDIDDNEP LFVRPPKGSP QYQLLTVPEH SPRGTLVGNV TGAVDADEGP
     NAIVYYFIAA GDEDKNFHLQ PDGRLLVLRD LDRETEATFS FIVKASSNRS WTPPRGPSPA
     LDLLTDLTLQ EVRVVLEDIN DQPPRFTKAE YTAGVATDAK VGSELIQVLA LDADIGNNSL
     VFYGILAIHY FRALANDSED VGQVFTMGSV DGILRTFDLF MAYSPGYFVV DIVARDLAGH
     NDTAIIGIYI LRDDQRVKIV INEIPDRVRG FEEEFIRLLS NITGAIVNTD DVQFHVDMKG
     RVNFAQTELL IHVVNRDTNR ILDVDRVIQM IDENKEQLRN LFRNYNVLDV QPAISVQLPD
     DMSALQMAII VLAILLFLAA MLFVLMNWYY RTIHKRKLKA IVAGSAGNRG FIDIMDMPNT
     NKYSFDGSNP VWLDPFCRNL ELAAQAEHED DLPENLSEIA DLWNSPTRTH GTFGREPAAV
     KPDDDRYLRA AIQEYDNIAK LGQIIREGPI KGSLLKVVLE DYLRLKKLFA QRMVQKASSC
     HSSISELIHT DLEEEPGDHS PGQGSLRFRH KPPMELKGQD GIHMVHGSTG TLLATDLNSL
     PEDDQKGLDR SLETLTASEA TAFERNARTE SAKSTPLHKL RDVIMESPLE ITEL
//
